Analyst firms · Morgan Stanley · APA
Morgan Stanley APA price target and rating history
APA Corporation (APA) · Energy
Morgan Stanley rates APA Corporation (APA) Equal-Weight with a $44 price target, as of its latest action on Jan 24, 2023. It has published 5 rating actions on APA since August 2021, including 0 upgrades and 1 downgrade. Across 7 firms with a APA price target in the last 12 months, the median target is $40.
- Current rating
- Equal-Weight
- Price target
- $44
- Median target, all firms
- $40
- Actions on APA
- 5
Morgan Stanley price target on APA
Every Morgan Stanley rating on APA
- Jan 24, 2023
- Jan 25, 2022
- Jan 3, 2022
- Oct 6, 2021
- Aug 23, 2021
How other firms rate APA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Scotiabank | Sector Perform | $44 | Oct 15, 2026 |
| Stifel | Buy | $62 | Sep 10, 2026 |
| Seaport Research Partners | Neutral | Sep 3, 2026 | |
| Argus Research | Buy | $48 | Aug 19, 2026 |
| Roth Capital | Buy | $38 | Jun 22, 2026 |
| Truist Securities | Hold | $38 | Mar 24, 2026 |
| Barclays | Equal Weight | $35 | Mar 23, 2026 |
| Johnson Rice | Accumulate | $40 | Dec 5, 2025 |
| William Blair | Outperform | Nov 26, 2025 |
Questions about Morgan Stanley and APA
- What is Morgan Stanley's price target for APA?
- Morgan Stanley's latest stated price target for APA Corporation (APA) is $44, from its action on Jan 24, 2023.
- What is Morgan Stanley's rating on APA?
- Morgan Stanley rates APA Equal-Weight, a neutral rating, as of Jan 24, 2023.
- When did Morgan Stanley last change its view on APA?
- On Jan 24, 2023, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $52 to $44.
- How does Morgan Stanley's APA target compare with other analysts?
- Across 7 firms with a APA price target in the last 12 months, the median target is $40.
More APA rating histories
All Morgan Stanley ratingsAPA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.